pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ASTRAZENECA · news · pharmadog
← back to ASTRAZENECA
News mentioning ASTRAZENECA
491
stories
Oct 6, 26
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
biopharma dive
Oct 6, 26
AstraZeneca heralds new R&D facility in that ‘other’ Cambridge
endpoints
Oct 6, 26
STAT+: AstraZeneca opens new Boston site
stat
Oct 6, 26
STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
stat
Oct 6, 26
Compliance concerns hinder rollout of AI in drug manufacturing: Survey
biospace
Oct 6, 26
The top biopharma conferences in 2027
biopharma dive
Oct 6, 26
AstraZeneca hopes to ‘achieve amazing things’ with new Kendall Square R&D center
fiercebiotech
Oct 5, 26
Biogen’s big lupus bet gets boost from new durability data for skin disease
biospace
Oct 5, 26
How AI is transforming biopharma manufacturing facilities of the future
biopharma dive
Oct 5, 26
Opinion: FDA must ensure American patients can access new and experimental drugs
biospace
Oct 2, 26
BMO most bullish on Merck's, bearish on BMS’ plans to contend with patent cliffs
biospace
Oct 2, 26
Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone
endpoints
Oct 1, 26
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
Oct 1, 26
Pfizer’s eczema drug clears skin in mid-stage trial
biopharma dive
Oct 1, 26
BMS reports liver injury events in lung disease program, with key readout near
biospace
Sep 30, 26
STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
stat
Sep 30, 26
$40M in tax incentives expected to generate 1,600+ life sciences jobs in Massachusetts
biospace
Sep 30, 26
STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
stat
Sep 30, 26
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
Sep 30, 26
Opinion: America’s biotech race with China must be won at home
stat
Sep 29, 26
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
stat
Sep 29, 26
STAT+: Overton won’t get a vote before midterms
stat
Sep 29, 26
Canadian $5M accelerated clinical trial program cuts start-up to 45 days
fiercebiotech
Sep 29, 26
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
stat
Sep 29, 26
Summit snags $2B investment from AstraZeneca, clearing financial overhang
biospace
Sep 29, 26
AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
biopharma dive
Sep 29, 26
AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos
fiercebiotech
Sep 28, 26
AstraZeneca buys a $2B stake in Summit, taking equity in bet on cancer drug
endpoints
Sep 28, 26
Merck licenses a KRAS G12D inhibitor for $400M upfront
endpoints
Sep 28, 26
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC
biopharma dive
← prev
page 5 of 17
next →